Quantification of thrombus Hounsfield units on noncontrast CT predicts stroke subtype and early recanalization after intravenous recombinant tissue plasminogen activator

American Journal of Neuroradiology

Volumn 33, Issue 1, 2012, Pages 90-96

  Puig, Josep ^a,b   Pedraza, S ^a   Demchuk, A ^c   Daunis i Estadella, J ^e   Termes, H ^a   Blasco, G ^a   Soria, G ^d   Boada, I ^e   Remollo, S ^a   Banos J ^a   Serena, J ^a   Castellanos, M ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF CALGARY   (Canada)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e UNIVERSITY OF GIRONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; AGED; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIAGNOSTIC ACCURACY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PREDICTIVE VALUE; QUANTITATIVE ANALYSIS; RECANALIZATION; RECEIVER OPERATING CHARACTERISTIC; STROKE; THROMBUS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CEREBRAL REVASCULARIZATION; COMBINED MODALITY THERAPY; CONTRAST MEDIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; PROGNOSIS; RECOMBINANT PROTEINS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856116146     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2878     Document Type: Note

References (38)

1. Tissue plasminogen activator for acute ischemic stroke: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-87
2. Bang OY, Liebeskind DS, Buck BH, et al. Impact of reperfusion after 3 hours of symptom onset on tissue fate in acute cerebral ischemia. J Neuroimaging. 2009;19:317-22
3. Bhatia R, Hill MD, Shobha N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010;41:2254-58
4. Wardlaw JM, Mielke O. Early signs of brain infarction at CT: observer reliability and outcome after thrombolytic treatment-systematic review. Radiology 2005;235:444-53 (Pubitemid 40571081)
5. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86
6. Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948-54 (Pubitemid 46568457)
7. Saqqur M, Tsivgoulis G, Molina CA, et al. Residual flow at the site of intracranial occlusion on transcranial Doppler predicts response to intravenous thrombolysis: a multi-center study. Cerebrovasc Dis 2009;27:5-12
8. Molina CA, Montaner J, Arenillas JF, et al. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 2004;35:486-90 (Pubitemid 38174434)
9. Abul-Kasim K, Brizzi M, Petersson J. Hyperdense middle cerebral artery sign is an ominous prognostic marker despite optimal workflow. Acta Neurol Scand 2010;122:132-39
10. Tomsick T, Brott T, Barsan W, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 1996;17:79-85 (Pubitemid 26024712)
11. Manelfe C, Larrue V, von Kummer R, et al. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke 1999;30:769-72 (Pubitemid 29156366)
12. Kim EY, Lee SK, Kim DJ, et al. Detection of thrombus in acute ischemic stroke: value of thin-section noncontrast-computed tomography. Stroke 2005; 36:2745-47
13. Kim EY, Heo JH, Lee SK, et al. Prediction of thrombolytic efficacy in acute ischemic stroke using thin-section noncontrast CT. Neurology 2006;67: 1846-48 (Pubitemid 44900765)
14. Castaigne P, Lhermitte F, Gautier JC, et al. Internal carotid artery occlusion: a study of 61 instances in 50 patients with post-mortem data. Brain 1970; 93:231-58
15. Kirchhof K, Welzel T, Mecke C, et al. Differentiation of white, mixed, and red thrombi: value of CT in estimation of the prognosis of thrombolysis phantom study. Radiology 2003;228:126-30 (Pubitemid 36736079)
16. Jang IK, Gold HK, Ziskind AA, et al. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator: a possible explanation for resistance to coronary thrombolysis. Circulation 1989;79:920-28 (Pubitemid 19100552)
17. Nogueira RG, Schwamm LH, Hirsch JA. Endovascular approaches to acute stroke. Part 1. Drugs, devices, and data. AJNR Am J Neuroradiol 2009; 30:649-61
18. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004;62:569-73 (Pubitemid 38252797)
19. Lansberg MG, Bluhmki E, Thijs VN. Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis. Stroke 2009;40:2438-41
20. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Group-the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-711 (Pubitemid 46691097)
21. Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-70 (Pubitemid 19188240)
22. Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999;30:1538-41 (Pubitemid 29379599)
23. AdamsHPJr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41
24. Pedraza S, Silva Y, Mendez J, et al. Comparison of preperfusion and postperfusion magnetic resonance angiography in acute stroke. Stroke 2004; 35:2105-10 (Pubitemid 39129569)
25. Leys D, Pruvo JP, Godefroy O, et al. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke 1992;23:317-24
26. Barber PA, Demchuk AM, Hudon ME, et al. Hyperdense sylvian fissure MCA "dot" sign: a CT marker of acute ischemia. Stroke 2001;32:84-88 (Pubitemid 32063828)
27. Williams DO, Borer J, Braunwald E, et al. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI Thrombolysis in Myocardial Infarction Trial. Circulation 1986;73:338-46 (Pubitemid 16127412)
28. Demchuk AM, Burgin WS, Christou I, el al. Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke 2001;32:89-93 (Pubitemid 32063829)
29. Baldi P, Brunak S, Chauvin Y, et al. Assessing the accuracy of prediction algorithms for classification: an overview. Bioinformatics 2000;16:412-24 (Pubitemid 30487963)
30. Blinc A, Kennedy SD, Bryant RG, et al. Flow through clots determines the rate and pattern of fibrinolysis. Thromb Haemost 1994;71:230-35 (Pubitemid 24047333)
31. Kim EY, Yoo E, Choi HY, et al. Thrombus volume comparison between patients with and without hyperattenuated artery sign on CT. AJNR Am J Neuroradiol 2008;29:359-62 (Pubitemid 351287896)
32. Von Kummer R, Meyding-Lamade U, Forsting M, et al. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol 1994;15:9-15
33. Qureshi AI, Ezzeddine MA, Nasar A, et al. Is intravenous tissue plasminogen activator beneficial in patients with hyperdense artery sign? Neurology 2006;66:1171-74 (Pubitemid 43739698)
34. Riedel CH, Jensen U, Rohr A, et al. Assessment of thrombus in acute middle cerebral artery occlusion using thin-slice nonenhanced computed tomography reconstructions. Stroke 2010;41:1659-64
35. Khatri P, Abruzzo T, Yeatts SD, et al. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066-72
36. Blinc A, Keber D, Lahajnar G, et al. Lysing patterns of retracted blood clots with diffusion or bulk flow transport of plasma with urokinase into clots: a magnetic resonance imaging study in vitro. Thromb Haemost 1992; 68:667-71
37. Blinc A, Keber D, Lahajnar G, et al. Magnetic resonance imaging of retracted and nonretracted blood clots during fibrinolysis in vitro. Haemostasis 1992;22:195-201
38. Truilaas P, Noghoghossian N, Derex L, et al. Thrombolysis with intravenous rtPA in a series of 100 cases of acute ischemic carotid territory stroke: determination of etiological, topographic and radiological outcome factors. Stroke 1998;29:2529-40 (Pubitemid 28544003)